Table 2 Prevalence of biopsy-confirmed CD in Asia–Pacific region among not at-risk population.
First author | Country | Region | Year of study | Population | Sample size | Age (mean) | Serology tests | Risk of bias | Prevalence of biopsy-confirmed (%) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
Male | Female | Total | |||||||||
Cook23 | New Zealand | Pacific | 2000 | Adults | 1064 | 50.2 | EMAa,b | Moderate | 5/448 (1.11) | 8/619 (1.29) | 13/1,064 (1.22) |
Hovell24 | Australia | Pacific | 2001 | Adults | 3011 | – | EMAa | Moderate | – | – | 7/3,011 (0.23) |
Shamir25 | Israel | Middle East | 2000–2001 | Adults | 1571 | 40.7 | t-TGa EMAa | Moderate | 8/1217 (0.65) | 2/354 (0.56) | 10/1571 (0.63) |
Shahbazkhani26 | Iran | Middle East | 2003 | Adults | 2000 | 35.5 | AGAa EMAa | Moderate | 10/1580 (0.63) | 2/420 (0.47) | 12/2000 (0.60) |
Israeli27 | Israel | Middle East | 2003 | Adults | 850 | 18 | t-TGa EMAa,b | Moderate | – | – | 6/850 (0.70) |
Tatar10 | Turkey | Middle East | 2001–2003 | Adults | 2000 | 33 | t-TGa,b | Moderate | 12/1914 (0.62) | 2/86 (2.32) | 14/2000 (0.70) |
Saberi-Firouzi11 | Iran | Middle East | 2004 | Adults | 1440 | 45.5 | t-TGa EMAa | Low | – | – | 2/1440 (0.14) |
Akbari28 | Iran | Middle East | 2003–2004 | Adults | 2795 | 33.7 | t-TGa EMAa | Low | 14/1398 (1) | 13/1401(0.92) | 27/2,799 (0.96) |
Sood29 | India | South Asia | 2003–2004 | Children | 4347 | 10.7 | t-TGa | Low | 4/2380 (0.16) | 10/1,976 (0.5) | 14/4,347 (0.32) |
Ertekin12 | Turkey | Middle East | 2005 | Children | 1263 | 11.9 | t-TGa | Moderate | 4/687 (0.58) | 3/576 (0.52) | 7/1,263 (0.55) |
Bahari30 | Iran | Middle East | 2006–2007 | Adults | 1600 | 33.2 | t-TGa,b | Moderate | 14/1418 (0.98) | 0/182 | 14/1600 (0.87) |
Dalgic13 | Turkey | Middle East | 2006–2008 | Children | 20,190 | 11.6 | t-TGa EMAa,b | Moderate | 34/10,368 (0.33) | 61/9,822 (0.62) | 95/20,190 (0.47) |
Farahmand31 | Iran | Middle East | 2006–2008 | Children | 634 | 12.8 | t-TGa | Moderate | – | – | 3/634 (0.47) |
Makharia16 | India | South Asia | 2008–2009 | Both | 10,488 | 22.45 | t-TGa | Moderate | 48/5,305 (0.91) | 61/5,183 (1.20) | 109/10,488 (1.04) |
Makharia16 | India | South Asia | 2008–2009 | Adults | 6845 | 34.4 | t-TGa | Moderate | – | – | 58/6,845 (0.85) |
Makharia16 | India | South Asia | 2008–2009 | Children | 3643 | 10.5 | t-TGa | Moderate | – | – | 51/3,643 (1.41) |
Bhattacharya32 | India | South Asia | 2009 | Children | 400 | 5.6 | t-TGa,b | Low | 1/228 (0.4) | 3/172 (1.7) | 4/400 (1) |
Sezgin18 | Turkey | Middle East | 2011–2013 | Adults | 1554 | 42.1 | t-TGa,b DGPa,b | Moderate | 0/772 | 6/782 (0.76) | 6/1,554 (0.39) |
Dehghani20 | Iran | Middle East | 2013 | Children | 1500 | 9.5 | t-TGa | Low | 4/825 (0.48) | 5/675 (0.74) | 9/1500 (0.6) |
Hatlani21 | Saudi Arabia | Middle East | 2012–2014 | Children | 1141 | 11 | t-TGa | Moderate | 4/454 (0.9) | 6/687 (0.9) | 10/1,141 (0.9) |
Fukunaga33 | Japan | East Asia | 2014–2016 | Adults | 2008 | 53 | t-TGa EMAa | Moderate | 1/1351 (0.07) | 0/657 | 1/2008 (0.05) |
